Möchten Sie immer auf dem neuesten Stand bleiben?

NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Optimove, the #1 CRM Marketing Solution for iGaming and Sports Betting, is pleased to announce the appointment of Adi Dagan as Senior Director of...

Los Angeles, California, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Timeless Builds, a team of expert swimming pool contractors in Los Angeles, are celebrating the premium quality customer service it...

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that...

Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "Cognitive Testing in Clinical Drug Trials: Successful Test Selection and Integration Training Course" conference has been added to ...

NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative...

MILAN, Sept. 05, 2024 (GLOBE NEWSWIRE) -- MUSIC BROKERS celebrates its 25th anniversary, marking a significant milestone in the global music industry. Since its founding in Buenos Aires in 1997 by...

LIFT-AD trial did not meet primary endpoint of GST and key secondary endpoints of cognition (ADAS-Cog11) and function (ADCS-ADL23)  In pre-specified subgroups of patients with moderate Alzheimer’s...

SAN MATEO, Calif., and CAMBRIDGE, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Kronos Bio, Inc. (Nasdaq: KRON), a company dedicated to developing small molecule therapeutics that address cancers and...

NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer, will present a corporate overview at the...

AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions PI-2620 is in Phase 3 development in Alzheimer’s disease by AC Immune’s...